Gene therapy: Therapeutic gene causing lymphoma

Nature

Volumn 440, Issue 7088, 2006, Pages 1123-

  Woods, Niels Bjarne ^a   Bottero, Virginie ^a   Schmidt, Manfred ^b,c,d   Von Kalle, Christof ^b   Verma, Inder M ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

^d UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2 RECEPTOR; LENTIVIRUS VECTOR; RECEPTOR SUBUNIT;

DISEASE; GENE; HEALTH CARE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER RISK; CONTROLLED STUDY; GENE THERAPY; IMMUNE DEFICIENCY; LYMPHOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; SCID MOUSE; SIGNAL TRANSDUCTION; T CELL LYMPHOMA; TRANSGENE;

ANIMALIA; LENTIVIRUS;

EID: 33646361846     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/4401123a     Document Type: Article

References (12)

1. Hacein-Bey-Abina, S. et al. N. Engl. J. Med. 346, 1185-1193 (2002).
2. Hacein-Bey-Abina, S. et al. Science 302, 415-419 (2003).
3. Soudais, C. et al. Blood 95, 3071-3077 (2000).
4. Otsu, M., Sugamura, K. & Candotti, F. Blood 97, 1618-1624 (2001).
5. Aviles Mendoza, G. J. et al. Mol. Ther. 3, 565-573 (2001).
6. Whitwam, T. et al. Blood 92, 1565-1575 (1998).
7. An, D. S. et al. J. Virol. 75, 3547-3555 (2001).
8. Larson, R. C., Osada, H., Larson, T. A., Lavenir, I. & Rabbitts, T. H. Oncogene 11, 853-862 (1995).
9. Lo, M. et al. Blood 94, 3027-3036 (1999).
10. Otsu, M. et al. Mol. Ther. 1, 145-153 (2000).
11. Otsu, M., Sugamura, K. & Candotti, F. Hum. Gene Ther. 11, 2051-2056 (2000).
12. Kersseboom, R. et al. J. Exp. Med. 198, 91-98 (2003).